Q2BI

Q2BI is a global contract research organization (CRO) for drug development and regulatory submissions since 2009. Q2BI offers services such as EDC & data management, statistical analysis, medical writing and monitoring, data visualization, intelligent data platforms, and PK/PD analysis to pharmaceutical, biotechnology and medical device partners. So far, Q2BI team has experienced over 1,500 studies and 47 NDA submissions in various therapeutic areas. With extensive experience, innovative solutions and the support of a high quality core technical team, Q2BI is committed to providing the highest quality services and the most reliable solutions, striving to maximize the chance of success for drug development at the lowest cost. Our Vision is to be the best-in-class global service provider to advance trials and improve health.